These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24473583)

  • 21. Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
    de Carvalho GA; Bahls SC; Boeving A; Graf H
    Thyroid; 2009 Jul; 19(7):691-7. PubMed ID: 19583486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.
    Papakostas GI; Kornstein SG; Clayton AH; Soares CN; Hallett LA; Krishen A; Tucker VL
    Int Clin Psychopharmacol; 2007 Jul; 22(4):226-9. PubMed ID: 17519646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
    Suri RA; Altshuler LL; Rasgon NL; Calcagno JL; Frye MA; Gitlin MJ; Hwang S; Zuckerbrow-Miller J
    J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
    Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?
    Nelson JC; Portera L; Leon AC
    Biol Psychiatry; 2005 Jun; 57(12):1535-42. PubMed ID: 15953490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.
    Cheer SM; Goa KL
    Drugs; 2001; 61(1):81-110. PubMed ID: 11217873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
    Newhouse PA; Krishnan KR; Doraiswamy PM; Richter EM; Batzar ED; Clary CM
    J Clin Psychiatry; 2000 Aug; 61(8):559-68. PubMed ID: 10982198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J
    J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
    Manoharan A; Shewade DG; Rajkumar RP; Adithan S
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.